経カテーテル心臓弁置換 (THVR) の世界市場 (2023-2030年)：製品・外科的アプローチ別の規模・シェア・成長分析・予測

世界の経カテーテル心臓弁置換 (THVR) の市場規模は、2021年の53億3,000万米ドル、2022年の57億1,000万米ドルから、予測期間中は7.2%のCAGRで推移し、2030年には106億8,000万米ドルの規模に成長すると予測されています。

THVRの市場は、技術の進歩、人口の高齢化、心血管疾患の増加により大きな成長を遂げています。経カテーテル技術は、従来の開心術に比べ、手術リスクの軽減と回復時間の短縮を実現します。市場をリードする企業は、機器の耐久性を高め、より幅広い患者層への適用を拡大するため、継続的に技術革新を行っています。同市場の拡大は、認知度の向上、有利な償還政策、医療専門家とメーカーの協力的な取り組みも原動力となっています。

市場動向

技術の進歩と革新がTHVR市場の情勢を再形成しています。これらの進歩により、高度で侵襲性の低い処置が実現しつつあります。注目すべき機能強化には、洗練された弁の構成、アップグレードされた画像診断法、新規の送達メカニズムなどがあります。この進化が、合併症を最小限に抑え、対応できる患者の幅を広げ、大動脈弁の状態に対処する最適なアプローチとしてTHVRが好まれる傾向を後押ししています。

当レポートでは、世界の経カテーテル心臓弁置換 (THVR) の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

親市場分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 主要市場洞察
  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要投資分析
  • 主要成功要因
  • 競合の程度
• 市場力学と展望
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制状況
  • ポーターの分析
  • 将来のディスラプションに関するSkyquestの特別な洞察
• 世界の経カテーテル心臓弁置換 (THVR) 市場：製品別
  • 市場概要
  • 経カテーテル大動脈弁置換
  • 経カテーテル僧帽弁の修復・交換
  • 経カテーテル肺動脈弁置換
• 世界の経カテーテル心臓弁置換 (THVR) 市場：外科的アプローチ別
  • 市場概要
  • 経大腿アプローチ
  • 経心尖アプローチ
  • 経大動脈アプローチ
• 世界の経カテーテル心臓弁置換 (THVR) 市場：地域別
  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 競合情勢
  • トップ5社の比較
  • 主要企業の市場での位置付け
  • 主要企業の採用戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア
  • 主要企業プロファイル
  • 4C Medical Technologies
  • Abbott
  • Boston Scientific
  • Edwards Lifesciences
  • HighLife Medical
  • JC Medical
  • LivaNova
  • Medtronic plc
  • Neovasc - Canada

Market Insights

Global Transcatheter Heart Valve Replacement Market size was valued at USD 5.33 billion in 2021 and is poised to grow from USD 5.71 billion in 2022 to USD 10.68 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

The Global Transcatheter Heart Valve Replacement Market encompasses the medical sector focused on minimally invasive heart valve procedures. This market has witnessed significant growth due to advancements in technology, an aging population, and rising cardiovascular diseases. Transcatheter techniques offer reduced surgical risks and quicker recovery times compared to traditional open-heart surgeries. Leading market players are continually innovating to enhance device durability and expand application to a broader patient base. This market's expansion is driven by increased awareness, favorable reimbursement policies, and collaborative efforts between medical professionals and manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of transcatheter heart valve replacement and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segmental Analysis

The global transcatheter heart valve replacement market is segmented on the basis of product, surgical approach, application, end user, and region. By Product, the market is segmented into Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair and Replacement, and Transcatheter Pulmonary Valve Replacement. By Surgical approach, the market is segmented into Transfemoral Approach, Transapical Approach, and Transaortic Approach. By Application, the market is segmented into Aortic Valve Stenosis, Aortic Valve Regurgitation, Aortic Valvular Heart Disease, Mitral Valvular Heart Disease, Mitral Valve Regurgitation, Mitral Valve Stenosis, and Pulmonary Valvular Heart Disease. By End user, the market is segmented into Hospitals, and Cath labs. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers

Factors such as the aging global populace and the growing prevalence of heart valve conditions like aortic stenosis are fueling the need for transcatheter heart valve replacement (THVR). With extended lifespans, the chances of encountering valve-related ailments are higher, thus enlarging the pool of patients seeking THVR interventions.

Restraints

Substantial Initial Expenses and Reimbursement Constraints:

Commencing THVR procedures involves significant financial outlays, encompassing device acquisition and specialized apparatus. Furthermore, obstacles in reimbursement coupled with divergent healthcare regulations across geographical areas might impede patient admission and moderate market proliferation.

Market Trends

Technological progress and innovations are reshaping the landscape of the Transcatheter Heart Valve Replacement (THVR) market. These advancements are yielding sophisticated and less invasive procedures. Notable enhancements include refined valve configurations, upgraded imaging methods, and novel delivery mechanisms, collectively ensuring safer and more efficient interventions. This evolution minimizes complications, broadens the spectrum of suitable patients, and propels the preference for THVR as the optimal approach to address aortic valve conditions.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune
• Research Methodology
• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Market Dynamics & Outlook
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Regulatory Landscape
• Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Transcatheter Heart Valve Replacement Market by Product
• Market Overview
• Transcatheter Aortic Valve Replacement
• Transcatheter Mitral Valve Repair and Replacement
• and Transcatheter Pulmonary Valve Replacement
• Global Transcatheter Heart Valve Replacement Market by Surgical Approach
• Market Overview
• Transfemoral Approach
• Transapical Approach
• and Transaortic Approach
• Global Transcatheter Heart Valve Replacement Market Size by Region
• Market Overview
• North America
• USA
• Canada
• Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
• By Development
• By Company
• By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021
• Key Company Profiles
• 4C Medical Technologies - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Abbott - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Boston Scientific - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Edwards Lifesciences - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• HighLife Medical - France
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• JC Medical - China
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• LivaNova - United Kingdom
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Medtronic plc - Ireland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Neovasc - Canada
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments